Trials / Completed
CompletedNCT01516489
Improving Fecal Occult Blood Test Completion Rates Among Veterans
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 1,549 (actual)
- Sponsor
- Corporal Michael J. Crescenz VA Medical Center · Federal
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a 4-arm cluster randomized controlled trial to evaluate whether patient financial incentives directly integrated into primary care can improve fecal occult blood test (FOBT) completion rates. We will recruit primary care patients at the Philadelphia Veterans Affairs Medical Center (PVAMC) in 2 stages. In stage 1, we hypothesize that, compared to usual care, $5, $10, $20 incentives will each lead to a statistically significant increase in the rate of FOBT completion. We also hypothesize that there will be a direct dose-response relationship between the incentive amount and rates of FOBT completion. In stage 2, we hypothesize that a lottery-based incentive and a raffle-based incentive will both lead to a statistically significant increase in the rate of FOBT completion compared to a fixed payment incentive with an equivalent dollar per patient value.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Stage 1 | Patients who are prescribed an FOBT kit in one of the PVAMC Primary Care clinics (i.e., Module B or C) will be randomly assigned by day to one of 4 study arms. All FOBT kits will include a card with a description of the arm that the patient has been randomized to. |
| BEHAVIORAL | Stage 2 | Patients who are prescribed an FOBT kit in one of the PVAMC Primary Care clinics (i.e., Module B or C) will be randomly assigned by day to one of 4 study arms. All FOBT kits will include a card with a description of the arm that the patient has been randomized to. The exact dollar amounts for the Voucher-Based Incentive, Lottery-Based Incentive, and Raffle-Based Incentive arms will be based on the results of Stage 1. |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2013-10-01
- Completion
- 2015-06-01
- First posted
- 2012-01-25
- Last updated
- 2015-10-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01516489. Inclusion in this directory is not an endorsement.